CRBU — Caribou Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Caribou Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	49.5	16	376	248	329
Net Total Accounts Receivable
Net Total Receivables	3.98	5.16	8.12	4.66	3.86
Prepaid Expenses
Total Other Current Assets
Total Current Assets	57	24.3	391	260	339
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.33	3.5	4.89	34.9	40.5
Long Term Investments
Other Long Term Assets
Total Assets	61.9	36	442	374	432
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10.1	12.4	25.8	28.1	28.3
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	13.1	18.2	54.5	72.9	63.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	48.8	17.9	388	301	368
Total Liabilities & Shareholders' Equity	61.9	36	442	374	432
Total Common Shares Outstanding